Background: Intraoperative anaphylaxis to neuromuscular blocking agents (NMBAs) is a rare event that is unpredictable and potentially life threatening. Most of the previous reports on such intraoperative anaphylaxis used market share surveys or self-reported data to estimate the incidence.
Objective: To determine the incidences of intraoperative anaphylaxis to NMBAs using electronic medical records.